Stay updated on NYX-2925 Efficacy & Safety in DPN Clinical Trial
Sign up to get notified when there's something new on the NYX-2925 Efficacy & Safety in DPN Clinical Trial page.

Latest updates to the NYX-2925 Efficacy & Safety in DPN Clinical Trial page
- Check2 days agoChange DetectedNo significant changes detected between the two screenshots; the page content and layout appear unchanged.SummaryDifference0.4%

- Check10 days agoNo Change Detected
- Check24 days agoChange DetectedAdded a prominent government funding notice and a new v3.2.0 version tag; removed the old v3.1.0 version tag.SummaryDifference3%

- Check38 days agoChange DetectedAdds v3.1.0 and removes several drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) while also removing the previous version v3.0.2; overall, the page’s scope appears to shift away from detailed drug-safety content.SummaryDifference0.4%

- Check53 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed.SummaryDifference0.2%

- Check60 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.2%

- Check68 days agoChange DetectedThe web page has been updated to include new information on diabetes, specifically focusing on Type 2 diabetes and related conditions, while removing some previous location details and references to diabetes complications.SummaryDifference3%

Stay in the know with updates to NYX-2925 Efficacy & Safety in DPN Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NYX-2925 Efficacy & Safety in DPN Clinical Trial page.